文献速递胃肠动力与功能性疾病

IBS患者结肠肥大细胞来源的PGE2诱导小鼠内脏高敏感

Prostaglandin E2, Produced by Mast Cells in Colon Tissues From Patients With Irritable Bowel Syndrome, Contributes to Visceral Hypersensitivity in Mice.
PubMed 文献 · Gastroenterology · 2020-02-19

本研究探讨IBS-D患者结肠肥大细胞来源的PGE2是否通过EP2受体促进内脏高敏感,采用ELISA和动物实验,发现患者结肠活检PGE2及COX2升高且主要位于肥大细胞,IBS-D上清液可致大鼠内脏高敏感,该效应依赖肥大细胞COX2和EP2。

要点

  • IBS-D患者结肠活检PGE2、COX2 mRNA及蛋白水平升高
  • IBS-D活检上清液诱导大鼠内脏高敏感,可被肥大细胞稳定剂、COX2抑制剂或EP2敲低阻止
  • 肥大细胞缺陷或Ptgs2Y385F小鼠中IBS-D上清液不诱导内脏高敏感

核心结论

  • 结肠肥大细胞异常合成PGE2可能诱导IBS-D患者内脏高敏感。

研究设计与样本

  • 采用ELISA检测IBS-D患者(18女5男,28-60岁)、健康对照(n=24)、小鼠和大鼠结肠黏膜肥大细胞自发释放分子水平。
  • 在啮齿类动物结肠内给予结肠活检上清液、组胺、PGE2、EP2小干扰RNA或PAR2激动剂后测量结直肠扩张的内脏运动反应。
  • 使用Ptgs2Y385F小鼠、肥大细胞缺陷W/WV小鼠及注射野生型或Ptgs2Y385F肥大细胞的W/WV小鼠研究肥大细胞COX2作用。

主要发现

  • IBS-D患者结肠活检PGE2水平及COX2 mRNA和蛋白较对照升高,免疫组化显示COX2主要位于肥大细胞。
  • 大鼠结肠内输注IBS-D活检上清液使内脏运动反应增加3-4倍,伴结肠黏膜PGE2、组胺和类胰蛋白酶显著升高。
  • 上述增加可被肥大细胞稳定剂、COX2抑制剂或EP2敲低阻止。
  • W/WV和Ptgs2Y385F小鼠中IBS-D上清液不诱导内脏高敏感或升高PGE2,W/WV小鼠重建肥大细胞后恢复内脏高敏感反应。

临床怎么用

  • IBS-D患者结肠肥大细胞COX2-PGE2-EP2通路可能为内脏高敏感提供干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Visceral hypersensitivity is common in patients with irritable bowel syndrome (IBS). We investigated whether inflammatory molecules, such as histamine and proteases, activate prostaglandin-endoperoxide synthase 2 (also called COX2) to increase the synthesis of prostaglandin E2 (PGE2) by mast cells, which activates the receptor PTGER2 (also called EP2) in the dorsal root ganglia to promote visceral hypersensitivity. METHODS: We used an enzyme-linked immunosorbent assay to measure levels of spontaneous release of molecules from mast cells in colonic mucosa from patients with IBS with diarrhea (IBS-D; 18 women and 5 men; aged 28-60 years), healthy individuals (controls, n = 24), mice, and rats. We measured visceromotor responses to colorectal distension in rodents after intracolonic administration of colon biopsy supernatants, histamine, PGE2, a small interfering RNA against EP2, or an agonist of F2R like trypsin receptor 1 (F2RL1, also called protease-activated receptor 2 [PAR2]). We investigated the role of COX2, produced by mast cells, in mediation of visceral hypersensitivity using mice with the Y385F substitution in Ptgs2 (Ptgs2Y385F mice), mast cell-deficient (W/WV) mice, and W/WV mice given injections of mast cells derived from wild-type or Ptgs2Y385F mice. RESULTS: Colon biopsies from patients with IBS-D had increased levels of PGE2, based on enzyme-linked immunosorbent assay, and COX2 messenger RNA and protein, compared with control biopsies. Immunohistochemistry showed that most of the COX2 was in mast cells. Intracolonic infusions of rats with IBS-D biopsy supernatants generated a 3- to 4-fold increase in visceromotor responses to colorectal distension; this was associated with significant increases in PGE2, histamine, and tryptase in the colonic mucosa. These increases were prevented by a mast cell stabilizer, COX2 inhibitor, or knockdown of EP2. Intracolonic administration of supernatants from biopsies of patients with IBS-D failed to induce visceral hypersensitivity or increase the level of PGE2 in W/WV and Ptgs2Y385Fmice. Reconstitution of mast cells in W/WV mice restored the visceral hypersensitivity response. CONCLUSIONS: Abnormal synthesis of PGE2 by colonic mast cells appears to induce visceral hypersensitivity in patients with IBS-D.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Grabauskas G, Wu X, Gao J, et al. Prostaglandin E2, Produced by Mast Cells in Colon Tissues From Patients With Irritable Bowel Syndrome, Contributes to Visceral Hypersensitivity in Mice. Gastroenterology. 2020. PMID: 32084424. doi:10.1053/j.gastro.2020.02.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。